Abstract S9 Table 1
Case NumberDiagnosisImmunosuppression RegimenAgeOnset of symptoms to ECMO initiation (days)CT DAD (%)CT Total Abnormality (%)SOFA ScoreCRP
1Eosinophilic pneumonia;
Hypereosinophilic syndrome
IVMP302110082.57344
3Eosinophilic pneumoniaIVMP2612080.09285
10Organising pneumoniaIVMP + CYC52301066.812226
11Acute interstitial pneumonitisIVMP + RTX441710088.811497
12Anti-Jo 1 associated acute interstitial pneumonitisIVMP + CYC + RTX42251082.111350
13DD: AIP, eosinophilic pneumonia,
Organising pneumonia
IVMP35199091.713266
Mean 38.220.751.782.010.5328
NON-RESPONDERS
2Acute interstitial pneumonitisIVMP + CYC5412988.468.4670
4Idiopathic pleuropulmonary fibroelastosisNone4514081.381.27117
5Acute Interstitial pneumonitis;
Organising pneumonia
IVMP + CYC + RTX plus heart lung transplant46265085.99153
6UnclassifiableIVMP + CYC + RTX204610096.7766
7Bleomycin-induced fibrosisIVMP462982.585.89111
8Clinically amyopathic
Dermatomyositis with acute interstitial pneumonitis
IVMP + RTX2917210095.6471
Mean 4090.383.785.67.098
P-values 0.790.040.190.530.010.046
  • Key: IVMP: Intravenous Methylprednisolone, RTX: Rituximab, CYC: Cyclophosphamide